Kapvay, the new clonidine extended-release for attention deficit hyperactivity disorder (ADHD) in children

February 2011

You'll see Rxs for Kapvay, the new clonidine extended-release for attention deficit hyperactivity disorder (ADHD) in children.

Clonidine (Catapres, etc) is already used in its short-acting form as an add-on to stimulants (Ritalin, etc) in some kids with ADHD.

But Kapvay is different than the immediate-release clonidine. It's extended-release...and doesn't affect people exactly the same way.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Pediatrics Just 1 or 2 doses of some medications can kill a young child
Acetaminophen Prescription combo pain meds (Lorcet, Tylox, etc) will be limited to only 325 mg of acetaminophen per tab or cap
Diabetes Meds Cycloset, a new form of bromocriptine for type 2 diabetes
Antidepressants confusion about which bupropion to dispense
Neurology & Pain Butrans (BYOO-trans), a new once-a-week C-III buprenorphine patch for chronic pain
Hemorrhoids which products to use for hemorrhoidal symptoms
Antipsychotics The new drug, Latuda (lurasidone), will compete in a crowded market of "atypical" antipsychotics (Zyprexa, Abilify, Invega, etc)
Pregnancy the differences in prenatal vitamins
Pediatrics Kapvay, the new clonidine extended-release for attention deficit hyperactivity disorder (ADHD) in children
Osteoporosis Atelvia (uh-TEL-vee-uh), increases the chance for mishaps with osteoporosis meds
Injectables the first INJECTABLE acetaminophen, Ofirmev (uh-FIRM-ev)
Medication Errors preventing mishaps with Catapres-TTS (clonidine) transdermal patches
New Drugs new drugs approved in 2010